Bortenat 3.5mg Injection
In stock
Description
Bortenat 3.5mg Injection contains bortezomib, a potent, reversible proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma by inducing cancer cell death. It works by inhibiting the 26S proteasome, disrupting regulatory protein breakdown, which causes cell cycle arrest and apoptosis. It is administered intravenously or subcutaneously.
Specifications
| Strength | 3.5 mg/vial |
|---|---|
| Storage | Store below 25°C, keep in a cool and dry place |
| Dosage Form | Injection (Vial) |
| Main Ingredients | Bortezomib 3.5mg |
